ondansetron Related Compounds
API
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
|
API | CS-O-00286 | 99614-02-5 |
Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
3-((2-hydroperoxy-2-methyl-2,5-dihydro-1H-imidazol-1-yl)meth... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-61230 | ---- | |
|
3-(hydroxymethyl)-9-methyl-2,3-dihydro-1H-carbazol-4(9H)-one R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-61229 | ---- | |
|
|
Impurity | CS-O-56555 | 247096-42-0 | |
|
6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-95905 | 1365727-09-8 | |
|
|
Impurity | CS-T-28369 | 126671-71-4 | |
|
9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,9-dihydro-1... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-61231 | ---- | |
|
N-((9-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methy... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-61232 | ---- | |
|
|
Impurity | CS-O-11323 | 153139-56-1 | |
|
|
Impurity | CS-EO-00049 | 153139-56-1 | |
|
|
Impurity | CS-O-31214 | 27387-31-1 | |
|
|
Impurity | CS-T-61834 | 99614-03-6 | |
|
|
Impurity | CS-O-51805 | 99614-04-07 | |
|
|
Impurity | CS-O-52598 | Not Available | |
|
|
Impurity | CS-O-31137 | 99614-64-9 | |
|
|
Impurity | CS-O-39816 | 99614-15-0 | |
|
|
Impurity | CS-O-35452 | Not Available | |
|
Ondansetron resolution Mixture RS (Ondansetron HCl and Ondan... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-57962 | 99614-01-4 + 119812-29-2 | |
|
|
Impurity | CS-O-31138 | 119812-29-2 |
![Structure - 6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one]](https://structures.clearsynth.com/CS-T-95905.png)
Metabolite
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
|
Metabolite | CS-T-15174 | 99614-14-9 |
Nitrosamine
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
N-Desmethyl N-Nitroso Hexahydroondansetron R&D Available for Back Order. For exact timeline please enquire |
Nitrosamine | CS-O-43797 | Not Available | |
|
|
Nitrosamine | CS-EO-02249 | Not Available |
Secondary Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
Ondansetron for LC system suitability(Secondary Standards tr... R&D Available for Back Order. For exact timeline please enquire |
Secondary Standards | CS-ER-02793 | 103639-04-9 |
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
|
Stable Isotopes | CS-T-103978 | 126671-71-4 (unlabelled) | |
|
|
Stable Isotopes | CS-T-101120 | 1076198-52-1 (Unlabelled) | |
|
|
Stable Isotopes | CS-O-06836 | 1225442-22-7 | |
|
|
Stable Isotopes | CS-CX-00758 | 1219798-86-3 |
Therapeutic
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
|
Therapeutic | CS-T-58164 | 1076198-52-1 | |
|
Ondansetron for LC system suitability (Y0000197) R&D Available for Back Order. For exact timeline please enquire |
Therapeutic | CS-EG-00503 | 103639-04-9 | |
|
Ondansetron for TLC system suitability (Y0000196) R&D Available for Back Order. For exact timeline please enquire |
Therapeutic | CS-EG-00502 | 103639-04-9 | |
|
Ondansetron for TLC system suitability(Secondary Standards t... R&D Available for Back Order. For exact timeline please enquire |
Therapeutic | CS-ER-02798 | 103639-04-9 | |
|
|
Therapeutic | CS-O-04933 | 99614-01-4 | |
|
|
Therapeutic | CS-O-02024 | 103639-04-9 | |
|
Ondansetron hydrochloride dihydrate(Secondary Standards trac... R&D Available for Back Order. For exact timeline please enquire |
Therapeutic | CS-ER-02796 | 103639-04-9 | |
|
|
Therapeutic | CS-EG-00508 | 103639-04-9 | |
|
Ondansetron impurity A(Secondary Standards traceble to EP) R&D Available for Back Order. For exact timeline please enquire |
Therapeutic | CS-ER-02792 | 103639-04-9 |
